Related Experiment Videos
Evaluating a filter device used for intermittent intravenous drug delivery to newborn infants
Insights
Comparing two neonatal drug delivery methods, the filter chamber infusion system demonstrated superior or equal performance to retrograde intravenous infusion for ensuring complete intermittent aminoglycoside doses at low flow rates.
Area of Science:
- Neonatal pharmacology
- Intravenous drug delivery systems
- Pharmacokinetics
Background:
- Aminoglycosides are crucial antibiotics for treating neonatal infections.
- Accurate drug delivery is vital in neonates due to their unique physiology.
- Intermittent dosing requires reliable administration methods.
Purpose of the Study:
- To compare the efficacy of a filter chamber infusion system versus retrograde intravenous (IV) infusion for delivering aminoglycosides in neonates.
- To evaluate drug recovery and concentration differences between the two infusion methods at low flow rates.
Main Methods:
- In vivo comparison of gentamicin and amikacin delivery in neonates using filter chamber and retrograde IV methods.
- In vitro testing of gentamicin recovery with both infusion systems.
- Measurement of peak and trough drug concentrations to calculate delta C (difference between peak and trough).
- Infusion flow rate maintained at 10 mL/hr for all tests.
Main Results:
- Gentamicin: The filter chamber method showed a significantly greater mean delta C (drug concentration difference) than retrograde infusion, indicating more complete delivery.
- Gentamicin: In vitro studies confirmed significantly better gentamicin recovery with the filter device.
- Amikacin: No significant difference in mean delta C was observed between the two methods, though the filter device was superior in more infants.
- Overall, the filter device was equal to or superior to retrograde infusion for intermittent aminoglycoside delivery in neonates at low flow rates.
Conclusions:
- The filter chamber infusion system is an effective and potentially superior method for delivering intermittent aminoglycoside doses in neonates compared to retrograde IV infusion.
- This finding supports the use of filter chamber systems for optimizing drug administration in vulnerable neonatal populations.
- Further research may explore the application of this system for other critical medications in neonates.
Abstract:
Injection of aminoglycosides into a filter chamber was compared with retrograde injection into i.v. tubing for delivery of intermittent drug dosages at low infusion rates in neonates. In 50 infants receiving gentamicin sulfate and 21 receiving amikacin sulfate for at least two days by retrograde i.v. infusion, peak and trough concentrations of the drugs were obtained. A subsequent dose was administered using the filter device, and peak and trough concentrations were obtained. For each infant, the difference between trough and peak concentration (delta C) was compared for the two methods. In vitro testing for gentamicin concentration was performed using the same infusion systems (10 trials for each system). For both in vivo and in vitro testing, the infusion flow rate was 10 mL/hr. For infants receiving gentamicin, delta C was greater for the filter device in 32, greater for retrograde infusion in 13, and equal in 5. The mean gentamicin delta C was significantly greater for the filter chamber method than for retrograde infusion. The in vitro studies showed significantly better gentamicin recovery with the filter device than with retrograde infusion. For amikacin, delta C was greater for the filter device in 15 infants, but the mean amikacin delta C was not significantly different for the two methods. At low flow rates commonly used in infants, the infusion system using the filter device was equal to or superior to retrograde infusion for ensuring complete delivery of intermittent drug doses.